|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Camargo MC, Goto Y, Zabaleta J, Morgan DR,
Correa P and Rabkin CS: Sex hormones, hormonal interventions, and
gastric cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers
Prev. 21:20–38. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lindblad M, Ye W, Rubio C and Lagergren J:
Estrogen and risk of gastric cancer: A protective effect in a
nationwide cohort study of patients with prostate cancer in Sweden.
Cancer Epidemiol Biomarkers Prev. 13:2203–2207. 2004.PubMed/NCBI
|
|
5
|
Wang M, Pan JY, Song GR, Chen HB, An LJ
and Qu SX: Altered expression of estrogen receptor alpha and beta
in advanced gastric adenocarcinoma: Correlation with prothymosin
alpha and clinicopathological parameters. Eur J Surg Oncol.
33:195–201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ryu WS, Kim JH, Jang YJ, Park SS, Um JW,
Park SH, Kim SJ, Mok YJ and Kim CS: Expression of estrogen
receptors in gastric cancer and their clinical significance. J Surg
Oncol. 106:456–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deng H, Huang X, Fan J, Wang L, Xia Q,
Yang X, Wang Z and Liu L: A variant of estrogen receptor-alpha,
ER-alpha36 is expressed in human gastric cancer and is highly
correlated with lymph node metastasis. Oncol Rep. 24:171–176.
2010.PubMed/NCBI
|
|
8
|
Wang XM, Liu JJ, Deng H, Chen Y and Liu
LJ: ER-α36 promotes the growth of SGC-7901 cells in nude mice.
World Chin J Digestol. 19:2919–2924. 2011.(In Chinese). View Article : Google Scholar
|
|
9
|
Wang ZY and Yin L: Estrogen receptor
alpha-36 (ER-α36): A new player in human breast cancer. Mol Cell
Endocrinol 418 Pt. 3:193–206. 2015. View Article : Google Scholar
|
|
10
|
Wang Z, Zhang X, Shen P, Loggie BW, Chang
Y and Deuel TF: Identification, cloning, and expression of human
estrogen receptor-alpha36, a novel variant of human estrogen
receptor-alpha66. Biochem Biophys Res Commun. 336:1023–1027. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Zhang X, Shen P, Loggie BW, Chang
Y and Deuel TF: A variant of estrogen receptor-{alpha},
hER-{alpha}36: Transduction of estrogen- and antiestrogen-dependent
membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA.
103:pp. 9063–9068. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng H, Zhang XT, Wang ML, Zheng HY, Liu
LJ and Wang ZY: ER-α36-mediated rapid estrogen signaling positively
regulates ER-positive breast cancer stem/progenitor cells. PLoS
One. 9:e880342014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J,
Wang T, Fan Z, Fan T, Lin B, et al: Expression of ER-{alpha}36, a
novel variant of estrogen receptor {alpha} and resistance to
tamoxifen treatment in breast cancer. J Clin Oncol. 27:3423–3429.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Huang X, Fu Z, Zou F, Li Y, Wang Z
and Liu L: Biphasic ER-α36-mediated estrogen signaling regulates
growth of gastric cancer cells. Int J Oncol. 45:2325–2330. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Deng H, Zou F, Fu Z, Chen Y, Wang
Z and Liu L: ER-α36-mediated gastric cancer cell proliferation via
the c-Src pathway. Oncol Lett. 6:329–335. 2013.PubMed/NCBI
|
|
16
|
Li Z and Li Z: Glucose regulated protein
78: A critical link between tumor microenvironment and cancer
hallmarks. Biochim Biophys Acta. 1826:13–22. 2012.PubMed/NCBI
|
|
17
|
Lee AS: GRP78 induction in cancer:
Therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee AS: Glucose-regulated proteins in
cancer: Molecular mechanisms and therapeutic potential. Nat Rev
Cancer. 14:263–276. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng HC, Takahashi H, Li XH, Hara T,
Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94
are markers for aggressive behavior and poor prognosis in gastric
carcinomas. Hum Pathol. 39:1042–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng CC, Lu N, Peng CL, Chang CC, Mai FD,
Chen LY, Liao MH, Wang WM and Chang J: Targeting to overexpressed
glucose-regulated protein 78 in gastric cancer discovered by 2D
DIGE improves the diagnostic and therapeutic efficacy of
micelles-mediated system. Proteomics. 12:2584–2597. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fu Y, Li J and Lee AS: GRP78/BiP inhibits
endoplasmic reticulum BIK and protects human breast cancer cells
against estrogen starvation-induced apoptosis. Cancer Res.
67:3734–3740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luvsandagva B, Nakamura K, Kitahara Y,
Aoki H, Murata T, Ikeda S and Minegishi T: GRP78 induced by
estrogen plays a role in the chemosensitivity of endometrial
cancer. Gynecol Oncol. 126:132–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu Z, Deng H, Wang X, Yang X, Wang Z and
Liu L: Involvement of ER-α36 in the malignant growth of gastric
carcinoma cells is associated with GRP94 overexpression.
Histopathology. 63:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu Z, Zhen H, Zou F, Wang X, Chen Y and
Liu L: Involvement of the Akt signaling pathway in
ER-α36/GRP94-mediated signaling in gastric cancer. Oncol Lett.
8:2077–2080. 2014.PubMed/NCBI
|
|
25
|
Hou J, Deng M, Li X, Liu W, Chu X, Wang J,
Chen F and Meng S: Chaperone gp96 mediates ER-α36 cell membrane
expression. Oncotarget. 6:31857–31867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fu ZQ, Yang Y, Song J, Jiang Q, Lin ZC,
Wang Q, Zhu LQ, Wang JZ and Tian Q: LiCl attenuates
thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β
in vivo and in vitro. J Alzheimers Dis. 21:1107–1117. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu Z, Zou F, Deng H, Zhou H and Liu L:
Estrogen protects SGC7901 cells from endoplasmic reticulum
stress-induced apoptosis by the Akt pathway. Oncol Lett. 7:560–564.
2014.PubMed/NCBI
|
|
28
|
Zhang S, Qiu C, Wang L, Liu Q and Du J:
The elevated level of ERα36 is correlated with nodal metastasis and
poor prognosis in lung adenocarcinoma. Steroids. 87:39–45. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin SL, Yan LY, Liang XW, Wang ZB, Wang
ZY, Qiao J, Schatten H and Sun QY: A novel variant of ER-alpha,
ER-alpha36 mediates testosterone-stimulated ERK and Akt activation
in endometrial cancer Hec1A cells. Reprod Biol Endocrinol.
7:1022009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Zheng N, Dong J, Wang X, Liu L and
Huang J: Estrogen receptor-α36 is involved in icaritin induced
growth inhibition of triple-negative breast cancer cells. J Steroid
Biochem Mol Biol. 171:318–327. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang XT, Kang LG, Ding L, Vranic S,
Gatalica Z and Wang ZY: A positive feedback loop of ER-α36/EGFR
promotes malignant growth of ER-negative breast cancer cells.
Oncogene. 30:770–780. 2011. View Article : Google Scholar : PubMed/NCBI
|
